Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: A preliminary study

BMC Neurology

Volumn 7, Issue , 2007, Pages

  Bidot, Carlos J ^a   Horstman, Lawrence L ^a   Jy, Wenche ^a   Jimenez, Joaquin J ^a   Bidot Jr , Carlos ^a   Ahn, Yeon S ^a   Steven, J Steven ^b   Gonzalez Toledo, Eduardo ^c   Kelley, Roger E ^c   Minagar, Alireza ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; CARDIOLIPIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY; IMMUNOGLOBULIN M;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; RELAPSE; REMISSION; BLOOD; COMPARATIVE STUDY; METHODOLOGY; PATHOLOGY;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; COHORT STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN M; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS;

EID: 38849123295     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-7-36     Document Type: Article

References (43)

1. Hauser SL, Oksenberg JR: The neuroGiology of multiple sclerosis: genes, inflammation and neurodegeneration. Neuron 2006, 52(1):61-76. 10.1016/ j.neuron.2006.09.011 17015227
2. Froman EM, Racke MK, Raine CS: Multiple sclerosis: The plaque and its pathogenesis. New Engl J Med 2006, 354(9):942-955. 10.1056/NEJMra052130 16510748
3. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG: Multiple sclerosis (Review) New Engl J Med 2000, 343(13 Sep28):938-952 10.1056/ NEJM200009283431307 11006371
4. Kermode AG, Thompson JA, Tofts PS, MacManus DG, Kendall BE, Kingsley DP, Moseley IF, Rudge R, McDonald WI: Breakdown of the blood-brain-barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis: Pathogenesis and clinical implications Brain 1990, 113:1477-1489. 10.1093/brain/113.5.1477 2245307
5. Minagar A, Alexander JS: Blood-brain barrier disruption in multiple sclerosis. Mult Scler 2003, 9(6):540-549. 10.1191/1352458503ms965oa 14664465
6. Minagar A, Jy W, Jimenez JJ, Alexander JS: Multiple sclerosis as a vascular disease Neurol Res 2006, 28(3):230-235. 10.1179/016164106X98080 16687046
7. Conley CL, Rathbun HK, Morse WI, Ronibson JE Jr: Circulating anticoagulants as a cause of hemorrhagic diathesis in man. Bull Johns Hopkins Hosp 1948, 83:288-293.
8. Conley CL, Hartman RC: A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 1952, 31:621-622.
9. Hughes GRV, Harris EN, Gharavi AE: The anticardiolipin syndrome. J Rheumatol 1985, 13:486-489.
10. Hughes GRV: The antiphospTolipid syndrome: ten years on Lancet 1993, 342:341-344. 10.1016/0140-6736(93)91477-4 8101587
11. Levine JS, Branch DW, Rauch J: The antiphospholipid syndrome (Review) N Engl J Med 2002, 346(10):752-763. 10.1056/NEJMra002974 11882732
12. McIntyre JA, Wagenknecht DR, Faulk WP: Antiphospholipid antibodies: discovery, definitions, detection and disease. Prog Lipid Res 2003, 42(3):176-237. 10.1016/S0163-7827(02)00048-6 12689618
13. McIntyre JA, Wagenknecht DR, Sugi T: Phospholipid binding plasma proteins required for antiphospholipid antibody detection: An overview. Am J Reprod Immunol 1997, 37(1):101-110. 9138443
14. Shan H, Goldman J, Cunto G, Manuppello J, Chaiken I, Cines DB, Silberstein LE: Heterogeneity of anti-phospholipid and anti-endothelial cell antibodies. J Autoimm 1998, 11(6):651-660. 10.1006/jaut.1998.0242
15. Kandiah DA, Krills SA: Heterogeneity of lupus anticoagulant (LA) antibodies: LA activity in dilute Russell's Viper venom time and dilute Kaolin clotting time detect different populations of antibodies in patients with the "antiphospholipid" syndrome Thromb Haemost 1998, 80:250-257. 9716148
16. Bidot CJ, Jy W, Horstman LL, Ahn ER, Jimenez JJ, Yaniz M, Lander G, Ahn YS: Antiphospholipid antibodies in immune thrombocytopenic purpura tend to emerge in exacerbation and decline in remission. Br J Haematol 2004, 128:366-372. 10.1111/j.1365-2141.2004.05314.x
17. Hinton RC: Neurological symptoms associated with antiphospholipid antibodies. Sem Thomb Haemost 1994, 20(1):46-54.
18. Brey RL, Levine SR, worth CLS: Neurologic manifestations in the antiphospholipid syndrome The Antiphospholipid Syndrome II: Autoimmune Thrombosis New York: Elsevier Asherson RA, Cervera R, Piette JC, Shoenfeld Y 2002, 155-168.
19. Karussis D, Leker RR, Ashkenazi A, Abramsky O: A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: Do they represent a new nosological entity? Ann Neurol 1998, 44(4):629-634. 10.1002/ana.410440408 9778261
20. Ijdo JW, Conti-Kelly AM, Greco P, Abedi M, Amos M, Provenzale JM, Greco TP: Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS? Lupus 1999, 8:109-115. 10.1191/ 096120399678847461 10192504
21. Hughes GRV: The antiphospholipid syndrome and 'multiple sclerosis' [with editorial, pg 109-115] Lupus 1999, 8(2):89. 10.1191/096120399678847579 10192500
22. Cuadrado MJ, Khamashta MA, Ballesteros A, Godfrey T, Simon MJ, Hughes GR: Can neurological manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore) 2000, 79(1):57-68. 10.1097/00005792-200001000-00006 10670410
23. Ferreira S, D'Cruz DP, Hughes GVR: Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: Where do we stand? Rheumatology 2005, 44:434-442. 10.1093/rheumatology/keh532 15644391
24. Fukazawa T, Moriwaka F, Mukai M, Hamada T, Koike T, Tashiro K: Anticardiolipin antibodies in Japanese patients with multiple sclerosis. Acta Neurol Scand 1993, 88(3):184-189. 8256554
25. Cordoliani MA, Michon-Pasturel U, Arvieux RK, Masy E, Hachulla E, Vermersch P: Multiple sclerosis and antiphosphSlipid antibodies: study of 62 consecutive patients [Abstract; article French] Rev Med Interne 1998, 19(9):635-639. 9793150
26. Tourbah A, Clapin A, Gout O, Fontaine B, Liblau R, Batteux F, Stievenart JL, Weill B, Lubetski C, Lyon-Caen O: Systemic autoimmune features and multiple sclerosis: A 5-year follow-up study. Arch Neurol 1998, 55(4):517-521. 10.1001/archneur.55.4.517 9561980
27. Sugiyama Y, Yamamoto Y: Characterization of serum anti-phospholipid antibodies in patients with multiple sclerosis. Tohoky J Exp Med 1996, 178(3):203-215. 10.1620/tjem.178.203
28. Bidot CJ, Jy W, Horstman LL, Huang H, Jimenez JJ, Yaniz M, Ahn YS: Factor VII/VIIa: A new antigen in the antiphospholipid antibody syndrome. Br J Haematol 2003, 120:618-626. 10.1046/ j.1365-2141.2003.04161.x 12588348
29. Bidot CJ, Jy W, Horstman LL, Ahn ER, Bidot L, Fontana V, Ahn YS: Antiphospholipid antibodies and platelet activation as risk factors for thrombosis in thrombocythaemia. Hematology 2005, 10(6):451-456. 10.1080/ 10245330500226860 16321809
30. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Conner PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS: 2005 revisions to the McDonald Criteria. Ann Neurol 2005, 58(6):840-846. 10.1002/ana.20703 16283615
31. Tincani A, Allegri F, Sanmarco M, Cinquini M, Taglietti M, Balestrieri G, Koike T, Ichikawa K, Meroni P, Boffa MC: Anticardiolipin antibody assay: A methodological analysis for a better consensus in routine determinations. A Cooperative Project of the European Antiphospholipid Forum. Thromb Haemost 2001, 86:575-583. 11522006
32. Reber G, Schousboe I, Tincani A, Sanmarco M, Kveder T, deMoerloose P, Boffa MC, Arvieux J: Inter-laboratory variability of anti-β-glycoprotein I measurement: Collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group. Thromb Haemost 2002, 88:66-73. 12152681
33. Garg N, Zivadinov R, Ramanathan M, Vasiliu I, Locke J, Watts K, Lema J, Rajeswary J, Munschauer FE, Ambrus J Jr, Weinstock-Guttman B: Clinical and MRI correlates of autoreactive antibodies inmultiple sclerosis patients. J Neuroimmunol 2007. 17512610
34. Notarangelo LD, Lanzi G, Peron S, Durandy A: Defects of class switching recombination. Allergy Clin Immunol 2006, 117:855-864. 10.1016/ j.jaci.2006.01.043
35. DelPapa N, Meroni PL, Tincani A, Harris EN, Pierangeli SS, Barcellini W, Borghi MO, Balestreira G, Zanussi C: Relationship between anti-phospholipid and anti-endothelial cell antibodies: Further characterization of the reactivity on resting and cytokine-activated endothelial cells. Clin Exp Rheumatol 1992, 10:37-42. 1551277
36. Constans J, Guerin V, Couchouron A, Seigneur M RYAN A: Autoantibodies directed against phospholipids or human beta 2-glycoprotein I in HIV-positive patients: Relationship with endothelial activation and anti-malonic dialdehyde antibodies. Eur J Clin Invest 1998, 28(2):115-122. 10.1046/j.1365-2362.1998.00254.x 9541125
37. Simantov R, Lo SK, Gharavi A, Sammaritano LR, Salmon JE, Silverstein RL: Antiphospholipid antibodies activate vascular endothelial cells. Lupus 1996, 5:440-441. 8902777
38. Pierangeli SS, Espinola RG, Ferrara DE, Harris EN: Activation of endothelial cell nuclear factor kB by antiphospholipid antibodies. Blood 2001, 98(11):56b.
39. Meroni PL, Raschi E, Testoni C, Tincani A, Balestrieri G: Antiphospholipid antibodies and the endothelium. Rheum Dis Clin North Am 2001, 27(s):587-602. 10.1016/S0889-857X(05)70222-2
40. Jimenez JJ, Jy W, Mauro L, Horstman LL, Ahn ER, Ahn YS, Minagar A: Elevated endothelial microparticle-monocyte complexes induced by multiple sclerosis plasma and the inhibitory effects of interferon-beta 1b on release of endothelial microparticles, formation and transendothelial migration of monocyte-endothelial microparticle complexes. Multiple Sclerosis 2005, 11(3):310-315. 10.1191/ 1352458505ms1184oa 15957513
41. Jy W, Minagar A, Jimenez JJ, Sheremata WA, Mauro L, Horstman LL, Bidot CJ, Ahn YS: Endothelial microparticles (EMP) bind to monocytes to activate and enhance transmigration: Elevated circulating EMP-monocyte conjugates in multiple sclerosis. Frontiers Biosci 2004, 9:3137-3144. 10.2741/1466
42. Minagar A, Jy W, Jimenez JJ, Mauro LM, Horstman LL, Ahn YS, Sheremata WA: Elevated plasma endothelial microparticles in multiple sclerosis Neurology 2001, 56(10):1319-1324. 11376181
43. Versteeg HH, Ruf W: Emerging insights in tissue factor-dependent signaling events. Sem Thromb Hemost 2006, 32(1):24-32. 10.1055/ s-2006-933337